about
Dendritic cell-based vaccines: barriers and opportunitiesLEAPS therapeutic vaccines as antigen specific suppressors of inflammation in infectious and autoimmune diseases.Rheumatoid arthritis vaccine therapies: perspectives and lessons from therapeutic ligand epitope antigen presentation system vaccines for models of rheumatoid arthritisAntigen-activated dendritic cells ameliorate influenza A infectionsLEAPS Vaccine Incorporating HER-2/neu Epitope Elicits Protection That Prevents and Limits Tumor Growth and Spread of Breast Cancer in a Mouse Model.An epitope-specific DerG-PG70 LEAPS vaccine modulates T cell responses and suppresses arthritis progression in two related murine models of rheumatoid arthritis
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
J-LEAPS peptide and LEAPS dendritic cell vaccines.
@en
J-LEAPS peptide and LEAPS dendritic cell vaccines.
@nl
type
label
J-LEAPS peptide and LEAPS dendritic cell vaccines.
@en
J-LEAPS peptide and LEAPS dendritic cell vaccines.
@nl
prefLabel
J-LEAPS peptide and LEAPS dendritic cell vaccines.
@en
J-LEAPS peptide and LEAPS dendritic cell vaccines.
@nl
P2093
P2860
P921
P1476
J-LEAPS peptide and LEAPS dendritic cell vaccines.
@en
P2093
Daniel H Zimmerman
Ken S Rosenthal
Patricia Taylor
P2860
P304
P356
10.1111/J.1751-7915.2011.00278.X
P577
2011-09-06T00:00:00Z
2012-03-01T00:00:00Z